Genor Biopharma Holdings Limited (FRA:67N0)
Germany · Delayed Price · Currency is EUR 0.3780
+0.0220 (6.18%)
At close: Nov 26, 2025
Genor Biopharma Holdings Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | 28.92 | -51.28 | -674.36 | -730.21 | -865.22 | -3,027 | Upgrade |
Depreciation & Amortization | 16.08 | 17.54 | 72.2 | 51.16 | 58.69 | 48.65 | Upgrade |
Other Amortization | 0.68 | 0.68 | 4.69 | 2.51 | 2.06 | 1.84 | Upgrade |
Loss (Gain) From Sale of Assets | 5.48 | 5.48 | 16.96 | 6.64 | 0.21 | 0.55 | Upgrade |
Asset Writedown & Restructuring Costs | 35.09 | 35.09 | 79.29 | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | 31.59 | 31.59 | 8.92 | - | - | - | Upgrade |
Stock-Based Compensation | 11.65 | 11.65 | 60.91 | 48.24 | 123.69 | 257.62 | Upgrade |
Other Operating Activities | 5.8 | -26.47 | 11.77 | -35.51 | 28.15 | 2,150 | Upgrade |
Change in Inventory | 0.7 | 0.7 | 7.91 | -4.71 | -22.34 | -7.66 | Upgrade |
Change in Accounts Payable | -58.84 | -58.84 | 9.5 | 2.49 | 37.93 | -11.63 | Upgrade |
Change in Unearned Revenue | -3.87 | -3.87 | 0.28 | -1.23 | -0.06 | -4.23 | Upgrade |
Change in Other Net Operating Assets | -84.24 | -84.24 | -23.18 | 83 | 13.15 | -194.72 | Upgrade |
Operating Cash Flow | -10.97 | -121.98 | -425.12 | -577.61 | -623.74 | -786.72 | Upgrade |
Capital Expenditures | -1 | -1.57 | -1.03 | -9.04 | -46.47 | -28.32 | Upgrade |
Sale of Property, Plant & Equipment | 3.82 | 9.58 | 7.02 | 0.02 | 0.62 | 0.05 | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | -3.92 | -24.92 | -69.98 | Upgrade |
Investment in Securities | 157.98 | - | - | - | 16.51 | - | Upgrade |
Investing Cash Flow | 160.81 | 8.01 | 5.99 | -12.94 | -54.26 | -98.24 | Upgrade |
Short-Term Debt Issued | - | - | - | 69.3 | 64.2 | - | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 119.98 | Upgrade |
Total Debt Issued | - | - | - | 69.3 | 64.2 | 119.98 | Upgrade |
Short-Term Debt Repaid | - | - | - | -99 | -34.5 | - | Upgrade |
Long-Term Debt Repaid | - | -1.45 | -5.94 | -19.7 | -12.49 | -18.52 | Upgrade |
Total Debt Repaid | 1.31 | -1.45 | -5.94 | -118.7 | -46.99 | -18.52 | Upgrade |
Net Debt Issued (Repaid) | 1.31 | -1.45 | -5.94 | -49.4 | 17.21 | 101.46 | Upgrade |
Issuance of Common Stock | - | - | 0 | - | 2.72 | 2,735 | Upgrade |
Repurchase of Common Stock | - | - | - | -5.13 | - | - | Upgrade |
Other Financing Activities | -0.04 | -0.11 | -0.89 | -2.86 | -2.36 | -111.25 | Upgrade |
Financing Cash Flow | 1.27 | -1.56 | -6.82 | -57.39 | 17.57 | 3,738 | Upgrade |
Foreign Exchange Rate Adjustments | 1.58 | 8.84 | 2.73 | 36 | -68.67 | -177.2 | Upgrade |
Net Cash Flow | 152.69 | -106.69 | -423.22 | -611.94 | -729.1 | 2,676 | Upgrade |
Free Cash Flow | -11.97 | -123.55 | -426.15 | -586.65 | -670.21 | -815.03 | Upgrade |
Free Cash Flow Margin | -5.34% | -59.91% | - | -3682.19% | - | -7889.19% | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.24 | -0.84 | -1.16 | -1.35 | -3.33 | Upgrade |
Cash Interest Paid | 0.04 | 0.11 | 0.89 | 2.86 | 2.36 | 2.03 | Upgrade |
Cash Income Tax Paid | 12.87 | 12.87 | - | - | - | - | Upgrade |
Levered Free Cash Flow | 96.96 | -30.01 | -220.51 | -371.35 | -402.54 | -583.59 | Upgrade |
Unlevered Free Cash Flow | 96.96 | -29.94 | -219.95 | -369.57 | -401.07 | -580.13 | Upgrade |
Change in Working Capital | -146.25 | -146.25 | -5.49 | 79.56 | 28.68 | -218.25 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.